Loss Per Share |
9 Months Ended | 12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Feb. 28, 2026 |
May 31, 2025 |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DIAMIR BIOSCIENCES CORP. [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Loss Per Share [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| LOSS PER SHARE | NOTE 12 — LOSS PER SHARE
The following common stock equivalents have been excluded from the calculation of loss per share because their effects would be antidilutive in the nine months ended February 28:
Additional shares are issuable under the Company’s convertible notes, the amount of which is dependent on future events. |
NOTE 13 — LOSS PER SHARE
The following common stock equivalents have been excluded from the calculation of loss per share because their effects would be antidilutive:
Additional shares are issuable under the Company’s convertible notes, the amount of which is dependent on future events. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||